Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center

Young-Wook Ryoo1, Ji-Min Yun1, Hyun-Wook Kim1

  • 1Department of Dermatology, Keimyung University School of Medicine, Daegu, Korea.

Annals of Dermatology
|December 7, 2023
PubMed

Insights

Pernio-like lesions, a skin condition, can occur after COVID-19 vaccination, particularly with mRNA vaccines. This study highlights four cases, suggesting this side effect may be more common than previously thought.

Area of Science:

  • Dermatology
  • Vaccinology
  • Immunology

Background:

  • South Korea offers mRNA (Moderna, Pfizer) and adenoviral vector (AstraZeneca, Janssen) COVID-19 vaccines.
  • Dermatologic side effects are known, ranging from injection site reactions to systemic rashes.
  • Pernio-like lesions, common in COVID-19, are rarely reported post-vaccination.

Observation:

  • Four cases of pernio-like lesions were observed within two months at a single tertiary hospital.
  • All cases occurred after the first dose of the mRNA-1273 (Moderna) vaccine.
  • The study details the clinical and pathological characteristics of these cases.

Findings:

  • Pernio-like lesions are a potential, albeit rare, cutaneous side effect of COVID-19 vaccination.
  • Comparison with existing literature suggests an underreporting of this specific side effect.
  • The observed cases provide further evidence linking mRNA vaccination to pernio-like reactions.

Implications:

  • Clinicians should be aware of pernio-like lesions as a possible adverse reaction to COVID-19 vaccines.
  • Increased recognition may lead to better patient management and understanding of vaccine-induced immune responses.
  • Real-world data suggests the incidence of this side effect might be higher than currently documented.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...